Tag - vaccines-medicine

 
 

VACCINES MEDICINE

Japan Times
JAPAN
Sep 1, 2021
Japan finds another Moderna vial suspected to contain foreign substance
Kanagawa Prefecture said it had put the suspected lot of the firm's COVID-19 vaccine on hold after about 3,790 people had already received shots from the same lot.
Japan Times
WORLD / Science & Health
Aug 27, 2021
Blood clot risk much higher for COVID-19 patients than from vaccines, study finds
The study followed 29 million people who received doses of either the AstraZeneca or Pfizer vaccine between December 2020 and April and about 1.7 million COVID-19 patients.
Japan Times
JAPAN
Jul 29, 2021
Even with delta surging, experts say two vaccine doses is enough for now
U.S. firm Pfizer Inc. has called for an additional third shot of its COVID-19 vaccine, citing new data showing its efficacy tails off after six months.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan Times
WORLD / Science & Health
Jul 7, 2021
Studies show vaccines are effective against delta variant
Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.
Japan Times
JAPAN
Jun 29, 2021
In Japan, anti-vaccine movement threatens to make widespread hesitancy worse
“Zero-risk worship” in Japan has made experts concerned about the impact that a fringe community of outspoken vaccine opponents could have on the public.
Japan Times
WORLD
Jun 28, 2021
Pfizer and Moderna vaccines likely produce long-lasting immunity
The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.
Japan Times
WORLD
Jun 21, 2021
COVID-19 counting enters new era as threat shifts away from cases
With rich countries vaccinating growing proportions of their vulnerable populations, the link between infection numbers and deaths appears to be diminishing.
Japan Times
JAPAN / FOCUS
Jun 4, 2021
In Japan, the light at the end of the pandemic's tunnel remains distant
The vaccine rollout may be accelerating, but the nation remains far away from a return to normalcy.
Japan Times
WORLD / Science & Health
May 28, 2021
AstraZeneca clot research continues amid German theory
German researchers said this week they discovered a link between the vaccine and rare blood clots.
Japan Times
WORLD / Science & Health
May 27, 2021
Immunity to the coronavirus may persist for years, scientists find
The findings may help put to rest lingering fears that protection against the virus will be short-lived.
Japan Times
WORLD / Science & Health
May 17, 2021
The man behind Brazil's search for miracle COVID-19 cures
One official's ascent reveals the central role that unproven treatments continue to play in Brazil.
Japan Times
EDITORIALS
May 8, 2021
World shares India’s pain with growing COVID-19 crisis
The WHO estimates that 25% of global deaths last week occurred in India, a death toll that exceeded 3,700 lives per day.
Japan Times
WORLD
May 4, 2021
White House backs Pfizer’s move to begin vaccine exports
Early U.S. production wasn't subject to an export ban but was gobbled up entirely by the government, which used wartime powers to prioritize its orders.
Japan Times
WORLD / Science & Health
May 1, 2021
Risk from virus variants remains after first Pfizer COVID-19 vaccine, U.K. study finds
A single dose of the vaccine may not generate a sufficient immune response to protect against dominant new variants, except in people who have already been infected with COVID-19.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?